Chargement en cours...
Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
The β-adrenergic agonists salbutamol and ephedrine have proven to be effective as therapies for human disorders of the neuromuscular junction, in particular many subsets of congenital myasthenic syndromes. However, the mechanisms underlying this clinical benefit are unknown and improved understandin...
Enregistré dans:
| Publié dans: | Hum Mol Genet |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6606850/ https://ncbi.nlm.nih.gov/pubmed/31220253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddz059 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|